Fennec Pharmaceuticals (FENC) Gross Margin (2023 - 2025)
Fennec Pharmaceuticals posted quarterly Gross Margin of 55.68% for Q4 2025, up 545.0% year-on-year from 8.63% in Q4 2024, and down 4.32% on a QoQ basis from 58.19% in Q3 2025.
Fennec Pharmaceuticals (FENC) has 3 years of Gross Margin data on file, last reported at 55.68% in Q4 2025.
- For the quarter ending Q4 2025, Gross Margin rose 545.0% year-over-year to 55.68%; the trailing twelve-month figure through Dec 2025 stood at 71.65% (down 621.0% YoY), and the FY2025 full-year result was 58.3%, down 294.0% from the prior year.
- Gross Margin for Q4 2025 stood at 55.68%, down from 58.19% in the prior quarter.
- Across five years, Gross Margin topped out at 97.83% in Q1 2024 and bottomed at 35.67% in Q2 2024.
- The 3-year median for Gross Margin is 91.47% (2023), against an average of 78.47%.
- The widest annual swing landed in 2024, when Gross Margin tumbled 5988 bps; it then soared 5432 bps in 2025.
- A 3-year view of Gross Margin shows it stood at 92.96% in 2023, then sank by 46 bps to 50.23% in 2024, then increased by 11 bps to 55.68% in 2025.
- The last three Gross Margin figures came in at 55.68% (Q4 2025), 58.19% (Q3 2025), and 89.98% (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 79.04% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 86.85% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 91.79% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 82.22% |
| 10 | Fennec Pharmaceuticals | 281.48 Mn | 244.70 Mn | 7.67 Mn | 55.68% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 55.68% |
| Sep 30, 2025 | 58.19% |
| Jun 30, 2025 | 89.98% |
| Mar 31, 2025 | 95.74% |
| Dec 31, 2024 | 50.23% |
| Sep 30, 2024 | 80.54% |
| Jun 30, 2024 | 35.67% |
| Mar 31, 2024 | 97.83% |
| Dec 31, 2023 | 92.96% |
| Sep 30, 2023 | 94.92% |
| Jun 30, 2023 | 95.55% |
| Mar 31, 2023 | 94.34% |